Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.69 USD | -2.87% | -7.14% | -49.25% |
06-07 | AbbVie's tight grip on Humira market raises concerns about biosimilars | RE |
06-05 | Coherus BioSciences, Inc. Appoints Rita Karachun to Its Board of Directors | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.25% | 200M | |
+18.72% | 125B | |
+14.19% | 108B | |
-4.93% | 24.57B | |
+3.23% | 22.82B | |
-10.44% | 18.19B | |
-41.74% | 16.54B | |
-13.31% | 16.5B | |
+2.44% | 13.39B | |
+27.89% | 11.1B |
- Stock Market
- Equities
- CHRS Stock
- News Coherus BioSciences, Inc.
- Barclays Adjusts Price Target on Coherus BioSciences to $13 From $15, Maintains Overweight Rating